Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. (2021)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01310-3
PubMed Identifier: 33723392
Publication URI: http://europepmc.org/abstract/MED/33723392
Type: Journal Article/Review
Volume: 124
Parent Publication: British journal of cancer
Issue: 10
ISSN: 0007-0920